Tonix Pharmaceuticals Hol...

NASDAQ: TNXP · Real-Time Price · USD
47.76
-11.82 (-19.84%)
At close: Aug 15, 2025, 10:04 AM

Tonix Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
10.09M 7.77M 9.03M n/a
Cost of Revenue
7.76M 4.74M 1M 62.86M
Gross Profit
2.33M 3.03M 8.03M -62.86M
Operating Income
-136.7M -118.38M -112.05M -92.39M
Interest Income
n/a n/a 1.87M 106K
Pretax Income
-130.04M -116.66M -110.22M -92.29M
Net Income
-130.04M -116.66M -116.88M -92.29M
Selling & General & Admin
40.1M 34.75M 30.21M 23.55M
Research & Development
39.97M 86.66M 81.88M 68.84M
Other Expenses
58.96M n/a n/a 29.48M
Operating Expenses
139.03M 121.41M 112.09M 92.39M
Interest Expense
n/a n/a 215K n/a
Selling & Marketing Expenses
36.7M n/a n/a n/a
Cost & Expenses
87.84M 126.15M 112.09M 92.39M
Income Tax Expense
n/a n/a 5.4M n/a
Shares Outstanding (Basic)
2.26M 1.83M 3.07M 7.05M
Shares Outstanding (Diluted)
2.26M 1.83M 3.07M 7.05M
EPS (Basic)
-176.6 -6.37K -811.68 -1.67K
EPS (Diluted)
-176.6 -6.37K -811.68 -1.67K
EBITDA
-126.61M -114.09M -110.84M -92.26M
EBIT
-130.04M -118.38M -112.09M -92.31M
Depreciation & Amortization
3.42M 4.29M 1.25M 50K